Dr. James O. Gesling

James O. Gesling joined the FDA in 1957, when he graduated college. He was the Executive Officer of the FDA’s Bureau of Veterinary Medicine.

When the Division of Biologics Standards (DBS) moved to the FDA in 1972, he became the Associate Director for Management and Compliance at what was then called the Bureau of Biologics.

Under Gesling the Bureau of Biologics launched a comprehensive investigation of the nation’s plasma businesses, closing dozens for dangerous practices and passing new regulations to address industry operations that put donors and recipients of plasma products at risk.